Aspect Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271 Hold
20
﹤0.01% 653
2026
Q1
$120 Hold
20
﹤0.01% 698
2025
Q4
$143 Hold
20
﹤0.01% 703
2025
Q3
$214 Hold
20
﹤0.01% 697
2025
Q2
$194 Hold
20
﹤0.01% 597
2025
Q1
$298 Hold
20
﹤0.01% 580
2024
Q4
$298 Hold
20
﹤0.01% 572
2024
Q3
$383 Hold
20
﹤0.01% 531
2024
Q2
$414 Hold
20
﹤0.01% 538
2024
Q1
$376 Hold
20
﹤0.01% 527
2023
Q4
$288 Buy
+20
New +$272 ﹤0.01% 521

Other funds holding OGN

Aspect Partners's OGN Position: Q2 2026 in Review

Aspect Partners held its Organon & Co (OGN) position steady in Q2 2026 at 20 shares worth $271. The position accounts for ﹤0.01% of the portfolio, ranked #653.

Aspect Partners first reported a position in OGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $414 in Q2 2024. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Aspect Partners held 20 shares of Organon & Co worth $271 as of Q2 2026.
  • Aspect Partners left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Aspect Partners's portfolio in Q2 2026, its #653 holding.
  • Aspect Partners first reported a position in Organon & Co in Q4 2023 and has held it in 11 quarters since.
  • Aspect Partners's Organon & Co position peaked at $414 in Q2 2024.
  • 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Aspect Partners's 13F filing for Q2 2026, filed 16 Jul 2026.